165 filings
Page 2 of 9
8-K
NPTX
Neuropathix, Inc.
17 Mar 21
Departure of Directors or Certain Officers
4:00pm
4
NPTX
Neuropathix, Inc.
16 Mar 21
NEUROPATHIX / ROBERT MALASEK ownership change
5:02pm
4
NPTX
Neuropathix, Inc.
16 Mar 21
NEUROPATHIX / Timothy Richard Scott ownership change
4:59pm
4
Schroeder Blake
16 Mar 21
NEUROPATHIX / Blake Schroeder ownership change
4:56pm
4
NPTX
Neuropathix, Inc.
16 Mar 21
NEUROPATHIX / Mark Corrao ownership change
4:53pm
4
Kikis Thomas Evangelos
16 Mar 21
NEUROPATHIX / THOMAS EVANGELOS KIKIS ownership change
4:50pm
4
Petkanas Dean
16 Mar 21
NEUROPATHIX / DEAN PETKANAS ownership change
4:47pm
4
NPTX
Neuropathix, Inc.
16 Mar 21
NEUROPATHIX / WILLIAM KINNEY ownership change
4:40pm
D
NPTX
Neuropathix, Inc.
23 Feb 21
$1.21M in equity / options / securities to be acquired, sold $1.21M, 1 investor
4:46pm
8-K
NPTX
Neuropathix, Inc.
23 Feb 21
Entry into a Material Definitive Agreement
4:01pm
8-K
NPTX
Neuropathix, Inc.
21 Dec 20
Neuropathix, Inc. Acquires Neuroprotective and Anticonvulsant Intellectual Property Estate
4:57pm
8-K
NPTX
Neuropathix, Inc.
19 Nov 20
Neuropathix, Inc. Signs Binding Letter of Intent to Acquire Anticonvulsant – Neuroprotective Intellectual Property
9:00am
10-Q
2020 Q3
NPTX
Neuropathix, Inc.
Quarterly report
12 Nov 20
11:36am
8-K
NPTX
Neuropathix, Inc.
6 Nov 20
Kannalife, Inc. Rebrands as Neuropathix, Inc.; Reveals New Name, Ticker Symbol, Updated Logo and Visual Identity
6:29am
EFFECT
NPTX
Neuropathix, Inc.
5 Oct 20
Notice of effectiveness
12:21am
CORRESP
NPTX
Neuropathix, Inc.
30 Sep 20
Correspondence with SEC
12:00am
UPLOAD
NPTX
Neuropathix, Inc.
29 Sep 20
Letter from SEC
12:00am
8-K
NPTX
Neuropathix, Inc.
22 Sep 20
Entry into a Material Definitive Agreement
2:33pm
S-1
NPTX
Neuropathix, Inc.
IPO registration
22 Sep 20
2:33pm
10-Q
2020 Q2
NPTX
Neuropathix, Inc.
Quarterly report
12 Aug 20
3:37pm